Rivercell
AI-powered drug discovery infrastructure building proprietary cell-response data and a predictive human cell world model.
Rivercell is a biotech & life sciences company based in Paris, FR, founded in 2026. It has raised $24.59 million in disclosed funding. Its latest round was a Seed of €22 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $24.6M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Rivercell do?
AI-powered drug discovery infrastructure building proprietary cell-response data and a predictive human cell world model.
How much has Rivercell raised?
Rivercell has raised $24.59 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Rivercell?
Investors in Rivercell include HV, HCVC, Alven, and Bpifrance Digital Venture.
When and where was Rivercell founded?
Rivercell was founded in 2026 and is based in Paris, FR.
Timeline
Founded
Sources
- 1.France’s Rivercell emerges from stealth with €22 million for AI-powered drug discovery infrastructure — EU-Startups, Oct 7, 2026